Abbing-Karahagopian, V. ., Huerta, C. ., Souverein, P. C., de Abajo, F. ., Leufkens, H. G., Slattery, J. ., … De Bruin, M. L. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
M. de Groot
First name
M.
Middle name
C.
Last name
de Groot
Afonso, A. ., Schmiedl, S. ., Becker, C. ., Tcherny-Lessenot, S. ., Primatesta, P. ., Plana, E. ., … Rottenkolber, M. . (2016). A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-016-2071-8
Huerta, C. ., Abbing-Karahagopian, V. ., Requena, G. ., Oliva, B. ., Alvarez, Y. ., Gardarsdottir, H. ., … de Abajo, F. J. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
Requena, G. ., Huerta, C. ., Gardarsdottir, H. ., Logie, J. ., Gonzalez-Gonzalez, R. ., Abbing-Karahagopian, V. ., … de Abajo, F. J. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816
Grimaldi-Bensouda, L. ., Klungel, O. ., Kurz, X. ., de Groot, M. C., Afonso, A. S. M., De Bruin, M. L., … Rossignol, M. . (2016). Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open. http://doi.org/10.1136/bmjopen-2015-009147